new approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
Clicks: 285
ID: 207622
2000
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
65.2
/100
278 views
227 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly population. The prevalence is reported to be 1.2-1.4% in several population-based epidemiological studies. Currently 25-30 million people worldwide are blind due to AMD. With the aging world population it is bound to increase significantly, and could become a significant public health problem in next two decades, with serious socio-economic implications. Several strategies are today available to treat the wet form of AMD, which is responsible for significant visual loss. These were until recently confined to laser photocoagulation, and subretinal surgery, but today two other modalities, namely, radiation and photodynamic therapy, are available. These treatment modalities however, are aimed at preservation of vision only, and not at reversing the process of the disease. Further research on antiangiogenic drugs and gene therapy could significantly help AMD patients.
| Reference Key |
lalit2000indiannew
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Verma Lalit;Das Taraprasad;Binder Susanne;Heriot Wilson;Kirchhof Bernd;Venkatesh Pradeep;Krebs Ilse;Stolba Ulrike;Jahn Christian;Feichtinger Hans;Kellner Lukas;Krugluger H;Pawelka I;Frohner Ursula;Kruger Andreas;Wenhua Li;Tewari Hem |
| Journal | Bioinformatics |
| Year | 2000 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.